MRNY
YieldMax MRNA Option Income Strategy ETF
MRNY
Closed
$43.46
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
MRNY was created on 2023-10-23 by YieldMax. The fund's investment portfolio concentrates primarily on health care equity. MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
Company
YieldMax
Asset class
Equity
Inception date
2023
Investment segment
Health Care
ISIN
US88636X2036
Website
Key stats
Open
$39.57
Volume
545.02K
AUM
$227.63M
Prev. close
$43.63
Expense ratio
1.00%
P/E
0.00
$39.47
Day’s Range
$43.73
$14.01
52W Range
$43.73
What’s in the fund
15
Total holdings
Mrna 11/20/2026 135.01 C
42.65%
OTHER ASSETS AND LIABILITIES
32.11%
United States Treasury Bills 0%
13.50%
United States Treasury Notes 2.38%
11.54%
United States Treasury Bills 0%
8.05%
United States Treasury Bills 0%
4.13%
First American Government Obligs X
3.13%
MRNA US 10/09/26 C207.5
1.83%
MRNA US 10/09/26 C205
0.37%
Others
-17.31%
Returns
Performance
_
Difference
_
YieldMax MRNA Option Income Strategy ETF
Oct
2
Dividends
The last payment date was Oct 2, 2026
Div. per Share
$0.81
Div. Yield
1.85%
Div. Growth YoY
-85.84%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply